Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Theravance Bio Ord (TBPH)

Theravance Bio Ord (TBPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 485,839
  • Shares Outstanding, K 49,174
  • Annual Sales, $ 57,420 K
  • Annual Income, $ -55,190 K
  • EBIT $ -44 M
  • EBITDA $ -44 M
  • 60-Month Beta 0.23
  • Price/Sales 8.43
  • Price/Cash Flow N/A
  • Price/Book 2.59

Options Overview Details

View History
  • Implied Volatility 88.10% ( +23.81%)
  • Historical Volatility 41.80%
  • IV Percentile 82%
  • IV Rank 55.51%
  • IV High 152.82% on 04/25/24
  • IV Low 7.35% on 10/11/24
  • Put/Call Vol Ratio 999.99
  • Today's Volume 3
  • Volume Avg (30-Day) 4
  • Put/Call OI Ratio 1.17
  • Today's Open Interest 239
  • Open Int (30-Day) 234

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.24
  • Number of Estimates 3
  • High Estimate -0.16
  • Low Estimate -0.33
  • Prior Year -0.17
  • Growth Rate Est. (year over year) -41.18%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.63 +14.48%
on 11/07/24
10.26 -3.70%
on 11/13/24
+1.17 (+13.43%)
since 11/06/24
3-Month
7.88 +25.38%
on 10/09/24
10.26 -3.70%
on 11/13/24
+1.87 (+23.35%)
since 09/06/24
52-Week
7.44 +32.80%
on 08/09/24
11.71 -15.63%
on 01/04/24
-0.63 (-5.99%)
since 12/06/23

Most Recent Stories

More News
Zacks Industry Outlook Madrigal, Corcept, Catalyst Larimar and Theravance

For Immediate ReleaseChicago, IL – November 11, 2024 – Today, Zacks Equity Research like Madrigal Pharmaceuticals MDGL, Corcept Therapeutics CORT, Catalyst Pharmaceuticals CPRX, Larimar Therapeutics...

CORT : 60.78 (+2.29%)
TBPH : 9.88 (+0.41%)
MDGL : 320.84 (+2.49%)
LRMR : 6.46 (+7.31%)
CPRX : 22.02 (+1.47%)
5 Small Drug Stocks to Buy as Trump Gets Re-Elected

The drug industry witnessed major policy changes during Joe Biden's four-year term as U.S. President, including the historic Inflation Reduction Act (“IRA”). With Donald Trump’s reelection, the biotech...

CORT : 60.78 (+2.29%)
TBPH : 9.88 (+0.41%)
MDGL : 320.84 (+2.49%)
LRMR : 6.46 (+7.31%)
CPRX : 22.02 (+1.47%)
Theravance Bio: Q4 Earnings Snapshot

Theravance Bio: Q4 Earnings Snapshot

TBPH : 9.88 (+0.41%)
Theravance Bio: Q3 Earnings Snapshot

Theravance Bio: Q3 Earnings Snapshot

TBPH : 9.88 (+0.41%)
Theravance Biopharma to Report Third Quarter 2023 Financial Results on November 7, 2023

/PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will report its third quarter 2023 financial results and provide a business update after market close...

TBPH : 9.88 (+0.41%)
Theravance Biopharma to Participate in an Upcoming Investor Conference

/PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will participate in a Fireside Chat at the H.C. Wainwright 25th Annual Global Investment Conference...

TBPH : 9.88 (+0.41%)
Theravance Biopharma to Present New Ampreloxetine Data at the 2023 International Congress of Parkinson's Disease and Movement Disorders

/PRNewswire/ -- Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced new ampreloxetine data in neurogenic...

TBPH : 9.88 (+0.41%)
Theravance Bio: Q2 Earnings Snapshot

Theravance Bio: Q2 Earnings Snapshot

TBPH : 9.88 (+0.41%)
Theravance Biopharma, Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update

Q2 2023 YUPELRI® (revefenacin) net sales of $55.0 million, recognized by Viatris, up 12% from Q2 20221 Q2 2023 YUPELRI total retail TRx and new to product TRx...

TBPH : 9.88 (+0.41%)
Theravance Biopharma to Report Second Quarter 2023 Financial Results on August 7, 2023

/PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will report its second quarter 2023 financial results and provide a business update after market...

TBPH : 9.88 (+0.41%)

Business Summary

Theravance Biopharma is a biopharmaceutical company primarily focused on discovering, developing and commercializing respiratory medicines. The company was formed following the split of the erstwhile Theravance into two listed companies in June 2014 - Innoviva, Inc. (then Theravance, Inc.) and Theravance.'...

See More

Key Turning Points

3rd Resistance Point 10.18
2nd Resistance Point 10.09
1st Resistance Point 9.99
Last Price 9.88
1st Support Level 9.79
2nd Support Level 9.70
3rd Support Level 9.60

See More

52-Week High 11.71
Fibonacci 61.8% 10.08
Last Price 9.88
Fibonacci 50% 9.57
Fibonacci 38.2% 9.07
52-Week Low 7.44

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar